In the Absence of a Cure, Good Care is What We Need Carol Berne Senior Vice President of Development -------------------------------------------------------------------------------- Earlier this month news broke that Lilly and AstraZeneca, two very large drug companies, abandoned Alzheimer’s drug trials for their late-stage Alzheimer’s treatment. This comes following the announcement in January that Pfizer plans to end its research efforts to discover new drugs for Alzheimer’s and Parkinson’s [...]